TEZSPIRE
TEZSPIRE
Approved
DIN Number
02529556
Drug Class
Human
Market Date
Oct 19, 2022
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02529556
AIG Number0163941001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
R03DX11 TEZEPELUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification48:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TEZEPELUMABActive
Strength: 110 MG / ML
Monograph: TEZEPELUMAB